Refractory Lung Carcinoma
1 clinical trials · Condition
◉ Watch Refractory Lung Carcinoma
| Record | Firm | Date |
|---|---|---|
| Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer (NCT02983578) | M.D. Anderson Cancer Center | 2017-03-02 |
Track Refractory Lung Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.